Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
High Content Screening, whether target-driven or purely phenotypic, is cost intensive and time consuming, ...
Cell-based multivariate phenotypic assays accelerate the identification of new drugs using disease-relevant ...